Antonia Exposito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Antonia Exposito has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Roberto Matorras
Human Reproduction Unit, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain
4 shared publications Begoña Prieto
Human Reproduction Unit, Cruces University Hospital. Biocruces, Basque Country University, Bilbao, Spain
3 shared publicationsLorena Crisol
3 shared publicationsRoberto Matorras
Human Reproduction Unit, Cruces University Hospital, Bilbao, Spain; Biocruces Health Research Institute, Basque Country University, Bilbao, Spain; Instituto Valenciano de Infertilidad, IVI Bilbao, Spain
3 shared publicationsRosario Mendoza
Department of Obstetrics and Gynecology, Cruces University Hospital, Baracaldo, and Department of Medical-Surgical Specialties, University of the Basque Country Universidad del País Vasco/Euskal Herriko Universitatea, Leioa, Spain; Biocruces, Health Research Institute, Grupo Clínico Vinculado from CIBER of Rare Diseases (CIBERER), Baracaldo, Spain
3 shared publicationsLucía Laínz
Department of Obstetrics and Gynecology, Cruces University Hospital, Baracaldo, and Department of Medical-Surgical Specialties, University of the Basque Country Universidad del País Vasco/Euskal Herriko Universitatea, Leioa, Spain; Biocruces, Health Research Institute, Grupo Clínico Vinculado from CIBER of Rare Diseases (CIBERER), Baracaldo, Spain
2 shared publications
Latest Publications
- 1 January 2020
- Published by Elsevier in Fertility and Sterility
- Vol. 113 (1) , 53-61
Oocytes of women who are obese or overweight have lower levels of n-3 polyunsaturated fatty acids compared with oocytes of women with normal weight
- 1 January 2020
- Published by Elsevier in Fertility and Sterility
- Vol. 113 (1) , 53-61
Oocytes of women who are obese or overweight have lower levels of n-3 polyunsaturated fatty acids compared with oocytes of women with normal weight
- 1 November 2019
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 39 (5) , 809-818
Influence of Caesarean section–pregnancy interval on uterine rupture risk and IVF pregnancy rates: systematic review and mathematical modelling
- 1 November 2019
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 39 (5) , 809-818
Influence of Caesarean section–pregnancy interval on uterine rupture risk and IVF pregnancy rates: systematic review and mathematical modelling
- 10 April 2018
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 297 (6) , 1577-1586
Proteomic pattern of implantative human endometrial fluid in in vitro fertilization cycles
Purpose To assess whether there are proteins in endometrial fluid aspirate (EFA) that predict implantation. Methods The population under study consisted of 285 women undergoing embryo transfer (ET). Endometrial fluid aspiration was performed immediately before ET. Results of proteomic analysis of EFA were compared between 33 cases who achieved pregnancy and 33 who did not. Samples were analysed by 2D electrophoresis and mass spectrometry. Blood samples were studied by ELISA Pregnancy rates and maternal complications were compared to those in women refusing aspiration. Results We found 23 proteins differentially expressed in the EFA in conception cycles: 4 up-regulated proteins and 19 down-regulated (FC = 0.31 0.78) (among others, arginase-1, actin B, PARK-7, cofilin-1, stathmin, annexin-2 and CAPZB). Among the five studied proteins that were differentially expressed in EFA, none was differentially expressed in serum. The aspiration procedure had no impact on pregnancy rate. No maternal complications were reported. Conclusions We found a very different protein profile in implantative cycles, the majority of proteins being down-regulated. This probably reflects a different endometrial functional status, more favourable to implantation. EFA proteomic analysis could be a useful tool in the planning ET strategies.
- 10 April 2018
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 297 (6) , 1577-1586
Proteomic pattern of implantative human endometrial fluid in in vitro fertilization cycles
Purpose To assess whether there are proteins in endometrial fluid aspirate (EFA) that predict implantation. Methods The population under study consisted of 285 women undergoing embryo transfer (ET). Endometrial fluid aspiration was performed immediately before ET. Results of proteomic analysis of EFA were compared between 33 cases who achieved pregnancy and 33 who did not. Samples were analysed by 2D electrophoresis and mass spectrometry. Blood samples were studied by ELISA Pregnancy rates and maternal complications were compared to those in women refusing aspiration. Results We found 23 proteins differentially expressed in the EFA in conception cycles: 4 up-regulated proteins and 19 down-regulated (FC = 0.31 0.78) (among others, arginase-1, actin B, PARK-7, cofilin-1, stathmin, annexin-2 and CAPZB). Among the five studied proteins that were differentially expressed in EFA, none was differentially expressed in serum. The aspiration procedure had no impact on pregnancy rate. No maternal complications were reported. Conclusions We found a very different protein profile in implantative cycles, the majority of proteins being down-regulated. This probably reflects a different endometrial functional status, more favourable to implantation. EFA proteomic analysis could be a useful tool in the planning ET strategies.
- 1 February 2018
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 36 (2) , 164-171
Risk of pelvic inflammatory disease after intrauterine insemination: a systematic review
- 1 February 2018
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 36 (2) , 164-171
Risk of pelvic inflammatory disease after intrauterine insemination: a systematic review
- 27 December 2011
- Vol. 56, 497-503
Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis.
To assess the value of the levonorgestrel-releasing intrauterine device (LNG-IUD) in the treatment of pelvic pain in patients with endometriosis in which previous medical and surgical treatments have failed. This prospective study evaluated pelvic pain by means of both a visual analog grading scale and a verbal descriptive grading scale. Pain was evaluated before insertion of the LNG-IUD and afterwards, at 3-month intervals. Adverse effects and reasons for removal were recorded. Me dian follow-up was 22 months (range, 3-36 months). Response rates were expressed as a percentage of the initial cohort in whom the LNG-IUD was inserted, including cases in which the LNG-IUD was extracted. Three months after LNG-IUD insertion, almost 50% of patients reported an improvement in pain symptoms, with this figure rising to 60% after 6 months and almost 70% by the end of follow-up. A trend of better responses was observed when endometriosis was diagnosed <10 years before, as well as in stage I-II endometriosis, but these differences were not statistically significant. In endometriosis patients with recurrent pelvic pain in whom previous medical and surgical treatments have failed, LNG-IUD insertion should be considered before radical surgery is performed.
- 27 December 2011
- Vol. 56, 497-503
Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis.
To assess the value of the levonorgestrel-releasing intrauterine device (LNG-IUD) in the treatment of pelvic pain in patients with endometriosis in which previous medical and surgical treatments have failed. This prospective study evaluated pelvic pain by means of both a visual analog grading scale and a verbal descriptive grading scale. Pain was evaluated before insertion of the LNG-IUD and afterwards, at 3-month intervals. Adverse effects and reasons for removal were recorded. Me dian follow-up was 22 months (range, 3-36 months). Response rates were expressed as a percentage of the initial cohort in whom the LNG-IUD was inserted, including cases in which the LNG-IUD was extracted. Three months after LNG-IUD insertion, almost 50% of patients reported an improvement in pain symptoms, with this figure rising to 60% after 6 months and almost 70% by the end of follow-up. A trend of better responses was observed when endometriosis was diagnosed <10 years before, as well as in stage I-II endometriosis, but these differences were not statistically significant. In endometriosis patients with recurrent pelvic pain in whom previous medical and surgical treatments have failed, LNG-IUD insertion should be considered before radical surgery is performed.
- 31 May 2011
- Published by Elsevier in Fertility and Sterility
- Vol. 95 (6) , 1937-1942.e3
Recombinant FSH versus highly purified FSH in intrauterine insemination: systematic review and metaanalysis
- 31 May 2011
- Published by Elsevier in Fertility and Sterility
- Vol. 95 (6) , 1937-1942.e3
Recombinant FSH versus highly purified FSH in intrauterine insemination: systematic review and metaanalysis
- 27 March 2010
- Vol. 55, 49-54
Daily workload in the embryology laboratory and in vitro fertilization results.
To ascertain if the daily activity in the in vitro fertilization (IVF) laboratory is related to pregnancy rates (PR) and fertilization rates (FR) in an IVF program. A retrospective study was performed to compare the PR and the FR obtained in 845 oocyte retrievals (OR) and 713 embryo transfers (ET), according to the daily workload. Different cutoffs were established: < or = 3 OR per day vs. > 3 OR per day; < or = 3 ET per day vs. > 3 ET per day, and also a cutoff considering the global activity in 3 different categories: optimal (level I), overload (level II) and high overload (level III), both the day of OR and of ET. The PR on the days with < or = 3 OR and with > 3 OR were similar, as were the days with < or = 3 ET or > 3 ET. There were no differences in PR when the activity the day of OR was level I, II or III (24.4%, 25.2% and 28.3%, respectively) or when the activity on the day of ET was level I, II or III (29.6%, 37.3% and 23.7%, respectively). We failed to show any adverse results on our IVF program associated with the daily workload.
- 27 March 2010
- Vol. 55, 49-54
Daily workload in the embryology laboratory and in vitro fertilization results.
To ascertain if the daily activity in the in vitro fertilization (IVF) laboratory is related to pregnancy rates (PR) and fertilization rates (FR) in an IVF program. A retrospective study was performed to compare the PR and the FR obtained in 845 oocyte retrievals (OR) and 713 embryo transfers (ET), according to the daily workload. Different cutoffs were established: < or = 3 OR per day vs. > 3 OR per day; < or = 3 ET per day vs. > 3 ET per day, and also a cutoff considering the global activity in 3 different categories: optimal (level I), overload (level II) and high overload (level III), both the day of OR and of ET. The PR on the days with < or = 3 OR and with > 3 OR were similar, as were the days with < or = 3 ET or > 3 ET. There were no differences in PR when the activity the day of OR was level I, II or III (24.4%, 25.2% and 28.3%, respectively) or when the activity on the day of ET was level I, II or III (29.6%, 37.3% and 23.7%, respectively). We failed to show any adverse results on our IVF program associated with the daily workload.